This interaction promoted NF-κB activation in a B-ALL cell line, consequently increasing B-ALL proliferation and CCL2 production, which further increased BM-MSC periostin expression [56]. The gene discussed is NFKB1; the disease is precursor B-cell acute lymphoblastic leukemia.